Project Grant HT9425261E103
Award Date 7/1/26
Completion Date 6/30/29
Dollars Obligated $1.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Milwaukee, WI 53233, USA
Similar Awards
- Federal Project Grant Award Summary Versiti Blood Health, Inc. received a $127,500 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 5, 2026, with a completion date of December 31, 2027. The award supports fundamental research investigating the role of force-directed lipid metabolism in the endothelial-to-hematopoietic transition...
- Federal Grant Award Summary Versiti Blood Health, Inc. received a $679,925 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on July 15, 2025, with a completion date of July 14, 2026. The award funds the acquisition of a Becton Dickinson Symphony S6 SE cell sorter—a five-laser, 49-detector fluorescence-activated cell sorting instrument—to be installed at the Versiti Blood Research Institute's flow...
- Federal Project Grant Award Summary Versiti Blood Health, Inc. received a $1,069,072 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective March 10, 2026 through December 31, 2032. The research project, titled "Decoding Kindlin-3 Signaling in Platelets and Neutrophils," focuses on elucidating the molecular mechanisms by which kindlin-3 regulates platelet activation during thrombosis and...
- Federal Grant Award Summary The University of Wisconsin-Madison received a $729,778 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning June 1, 2025 and concluding May 31, 2028. The award supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting—research aimed at identifying and developing novel diagnostic markers and treatment approaches through comprehensive molecular...
- Federal Grant Award Summary The University of Wisconsin–Madison received a $777,500 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2025 through May 31, 2028. This award supports a multiomic analysis research initiative focused on liquid biopsies for biomarker discovery and therapeutic targeting. The project will deliver advanced biomedical research capabilities aimed at identifying and...
- Federal Grant Award Summary The University of Wisconsin – Madison received a $500,000 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded August 1, 2025, with performance through July 31, 2027. The project delivers research and development services focused on developing and testing a novel immune inhibitory transgene for delivery to vascular composite allografts during normothermic preservation. The primary objective...
- Federal Project Grant Award Summary Functional Circulation LLC received a $621,943 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of September 30, 2025, through September 29, 2028. The award supports advanced biomedical research investigating the DPEP1-neutrophil axis in microsatellite stable colorectal cancer. The project will be conducted at the company's facility in Lake Mills, Wisconsin, and is...
- Federal Project Grant Award Summary Vascular Perfusion Solutions Inc. received an $818,337 Project Grant award dated August 15, 2025, from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The award supports research and development of extended limb stasis capabilities within the ENCORE Tissue Preservation Device, with performance through August 14, 2027, at the awardee's San Antonio, Texas facility. This modification to the existing award...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the University of Wisconsin–Madison a $1,074,650 project grant under the Military Medical Research and Development program (CFDA 12.420) on September 1, 2025, with an ultimate completion date of August 31, 2029. The grant supports investigation of the immunomodulatory effects of chemokine signaling in renal cell carcinoma, representing a hypothesis-driven biomedical research initiative designed to advance innovative...
- Federal Grant Award Summary 149 Bio LLC received a $5.1M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2025 through June 30, 2029. The award supports the development of a myeloid-targeted novel therapeutic intervention for glomerular diseases. This research initiative will be conducted at the awardee's facility in Miami, FL and aims to advance biomedical solutions relevant to military health...